株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

セルベースアッセイ (CBA) の世界の産業・市場 (2018年~2028年)

Cell-Based Assays World Industry and Market 2018-2028

発行 Visiongain Ltd 商品コード 233145
出版日 ページ情報 英文 241 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=146.83円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

Back to Top
セルベースアッセイ (CBA) の世界の産業・市場 (2018年~2028年) Cell-Based Assays World Industry and Market 2018-2028
出版日: 2018年09月18日 ページ情報: 英文 241 Pages
概要

セルベースアッセイ (CBA) 市場の収益は、2018年~2023年のCAGR (複合年間成長率) で、9.2%の成長が予測されています。

当レポートでは、世界のセルベースアッセイ (CBA) 市場について調査分析し、市場概要、主要促進要因と課題、セグメント別の市場分析、国別の収益予測、SWOT/STEP分析、主要企業などについて、体系的な情報を提供しています。

第1章 レポート概要

第2章 イントロダクション:セルベースアッセイ (CBA) とその応用

  • 新薬の発見・開発コストが26億米ドルに達する
  • 創薬のアプローチ:標的ベースと表現型ベース
  • 薬剤スクリーニングアッセイ
  • 動物モデルはIn Vivo:ヒトへの適応は
  • 生化学アッセイと動物モデルに勝るメリット
  • セルベースアッセイ (CBA) とそのメリット
  • 2D vs. 3D セルベースアッセイ (CBA)
  • 先進のセルベースアッセイ (CBA)
  • さまざまなアッセイの検出手法と技術
  • セルベースアッセイ (CBA) に用いられる細胞
  • 創薬・開発におけるセルベースアッセイ (CBA) の利用

第3章 世界のセルベースアッセイ (CBA) 市場

  • 市場予測
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 動向
  • 製品タイプ別:予測
    • 機器
    • 消耗品
    • ソフトウェア
    • サービス
  • 応用別:予測
  • エンドユーザー別:予測

第4章 セルベースアッセイ (CBA) の主要国市場

  • 地域別内訳
  • 地域別予測
  • 米国
  • EU
  • 日本
  • BRIC諸国

第5章 セルベースアッセイ (CBA) 市場の主要企業

  • DiscoverX Corporation (Eurofins)
  • Thermo Fisher Scientific
  • Cell Assay Innovations, Inc.
  • InSphero AG
  • QGel SA
  • Becton, Dickinson and Company
  • Promega Corporation
  • BioVision, Inc.
  • Marin Biologic Laboratories
  • Molecular Devices, LLC. (Danaher Corporation)
  • Porsolt
  • CYTOO SA
  • Pharmaceutical Product Development, LLC.
  • ProQinase GmbH
  • Charles River Laboratories International, Inc.
  • BioAgilytix Labs
  • SGS Group
  • Perkin Elmer Inc.
  • General Electric Company (GE Healthcare)

第6章 セルベースアッセイ (CBA) 技術、動向、将来の見通し

  • 幹細胞:膨大な可能性
  • 毒性試験:セルベースアッセイ (CBA) の重要分野
  • 3Dシステム:次世代細胞システムのメリット
  • セルベースアッセイ (CBA) のアウトソーシングの増加
  • ラベルフリー技術
  • GPCR:共通の薬剤・創薬の標的
  • 小型化とオートメーションの増加
  • マイクロ流体
  • 多重化:セルベースアッセイ (CBA) の効率化
  • ハイコンテントスクリーニング (HCS) :確立されたツール
  • 生物製剤の開発におけるセルベースアッセイ (CBA)

第7章 セルベースアッセイ (CBA) 市場の定性分析

  • SWOT分析
  • STEP分析

第8章 結論

付録

図表

List of Tables

  • Table 1.1: Global Cell-Based Assays Market Regional Forecasts: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2016-2026
  • Table 2.1: Main Parameters Required in Drug Discovery and Development
  • Table 2.2: Selected Label-Free Detection Technologies Used for Cell-Based Assays, 2016
  • Table 2.3: Cell-Based Assays for HTS in Drug Screening, 2016
  • Table 3.1: Global Cell-Based Assays Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2026
  • Table 3.2: Global Cell-Based Assays Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2026
  • Table 3.3: Cell-Based Assays Market Segments: Products Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2016-2026
  • Table 3.4: Cell-Based Assays Market Segments: Services Forecast- Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
  • Table 3.5: Cell-Based Assays Market Application Forecasts: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
  • Table 3.6: Drug Discovery Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2016-2026
  • Table 3.7: ADME Segment Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
  • Table 3.8: Basic Research Segment Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
  • Table 4.1: Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2015
  • Table 4.2: Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2020
  • Table 4.3: Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2026
  • Table 4.4: Global Cell-Based Assays Market Regional Forecasts: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2016-2026
  • Table 4.5: US Cell-Based Assays Market Forecast: Revenues ($m), AGR (%),Market Shares (%), CAGR (%), 2016-2026
  • Table 4.6: EU Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), World Market Shares (%), CAGR (%), 2016-2026
  • Table 4.7: EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2015
  • Table 4.8: EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2020
  • Table 4.9: EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2026
  • Table 4.10: EU Market, Leading Five National Forecasts: Revenue ($m), AGR (%),Market Share (%), CAGR (%), 2016-2026
  • Table 4.11: German Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.12: French Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.13: UK Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.14: Spanish Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Table 4.15: Italian Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Table 4.16: Japanese Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Table 4.17: BRIC Countries Breakdown by Nation: BRIC market Shares (%), Global Market Shares (%) and Revenues ($m), 2015
  • Table 4.18: BRIC Countries Breakdown by Nation: EU market Shares (%), Global Market Shares (%) and Revenues ($m), 2020
  • Table 4.19: BRIC Countries Breakdown by Nation: EU market Shares (%), Global Market Shares (%) and Revenues ($m), 2026
  • Table 4.20: BRIC National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.21: Chinese National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.22: Indian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.23: Russian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.24: Brazilian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 5.1: ThermoFisher Scientific Historical Sales: Revenue ($m), AGR (%), 2010-2015
  • Table 5.2: Life Technologies Cell-Based Assay Technology Overview, 2016
  • Table 5.3: Life Technologies Cell-Based Assay Technology Overview, 2016
  • Table 5.4: Other DiscoveRx Assay Platforms, 2016
  • Table 5.5: PerkinElmer Revenue Breakdown: Revenue ($m) for Fiscal Year Ending 3rd January 2016
  • Table 5.6: QGel Products and Services Cell-Based Assay Products, 2016
  • Table 5.7: GE Healthcare Life Sciences Cell-Based Assay Products, 2016
  • Table 6.1: ProQinase Cell-Based Assay Services, 2016
  • Table 6.2: Charles River Laboratories Revenue Breakdown: Revenue ($m), 2013-2015
  • Table 6.3: Cell-Based Assay Platforms, Details and Benefits Used by BioAgilytix , 2016
  • Table 7.1: Selected Companies with Involvement in Stem Cell-Based Assays, 2016
  • Table 7.2: Selected Companies Offering Label-Free Assay Systems, 2016

List of Figures

  • Figure 1.1: Cell-Based Assays Market Segmented by Application
  • Figure 1.2: Cell-Based Assays Market Segmented by Sector
  • Figure 1.3: Cell-Based Assays Products Market Segments
  • Figure 2.1: Stages of Pre-Clinical Drug Development
  • Figure 3.1: Global Cell-Based Assays Market Forecast: Revenue ($m), 2016-2026
  • Figure 3.2: Drivers and Restraints for the Cell-Based Assays Market, 2016
  • Figure 3.3: Cell-Based Assays Market Segments Forecasts: Revenue ($m), 2016-2026
  • Figure 3.4: Cell-Based Assays Market Segments: Products Forecast - Revenue ($m), 2016-2026
  • Figure 3.5: Cell-Based Assays Market Segments: Products Forecast - AGR (%), 2016-2026
  • Figure 3.6: Cell-Based Assay Products Overview, 2016
  • Figure 3.7: Cell-Based Assays Market Segments: Services Forecast - Revenue ($m), 2016-2026
  • Figure 3.8: Cell-Based Assays Market Segments: Services Forecast - AGR (%), 2016-2026
  • Figure 3.9: Cell-Based Assays Market Application Forecasts: Revenue ($m), 2016-2026
  • Figure 3.10: Drug Discovery Segment Forecast: Revenue ($m), 2016-2026
  • Figure 3.11: Drug Discovery Segment Forecast: AGR (%), 2016-2026
  • Figure 3.12: ADME Segment Forecast: Revenue ($m), 2016-2026
  • Figure 3.13: ADME Segment Forecast: AGR (%), 2016-2026
  • Figure 3.14: Basic Research Segment Forecast: Revenue ($m), 2016-2026
  • Figure 3.15: Basic Research Segment Forecast: AGR (%), 2016-2026
  • Figure 4.1: Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2015
  • Figure 4.2: Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2020
  • Figure 4.3: Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2026
  • Figure 4.4: Global Cell-Based Assays Market, Regional Forecasts: Revenues ($m), 2016-2026
  • Figure 4.5: US Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Figure 4.6: US Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.7: EU Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Figure 4.8: EU Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.9: EU Market Breakdown by Nation: EU Market Shares (%), 2015
  • Figure 4.10: EU Market Breakdown by Nation: Revenues ($m), Market Shares (%), 2020
  • Figure 4.11: EU Market Breakdown by Nation: Revenues ($m), Market Shares (%), 2026
  • Figure 4.12: EU Market, Top National Forecasts: Revenue ($m), 2016-2026
  • Figure 4.13: German Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Figure 4.14: German Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.15: French Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Figure 4.16: French Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.17: UK Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Figure 4.18: UK Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.19: Spanish Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.20: Spanish Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.21: Italian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.22: Italian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.23: Japanese Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.24: Japanese Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.25: BRIC Countries Breakdown by Nation: Market Shares (%), 2015
  • Figure 4.26: BRIC Countries Breakdown by Nation: Market Shares (%), 2020
  • Figure 4.27: BRIC Countries Breakdown by Nation: Market Shares (%), 2026
  • Figure 4.28: BRIC Countries Breakdown by Nation: Revenues ($m), 2016-2026
  • Figure 4.29: Chinese Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.30: Chinese Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.31: Indian Cell-Based Assays Market Forecast: Revenue ($m), 2016-2026
  • Figure 4.32: Indian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.33: Russian Cell-Based Assays Market Forecast: Revenue ($m), 2016-2026
  • Figure 4.34: Russian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.35: Brazilian Cell-Based Assays Market Forecast: Revenue ($m), 2016-2026
  • Figure 4.36: Brazilian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 5.1: ThermoFisher Scientific Historical Sales: Revenue ($m), 2010-2015
  • Figure 5.2: PerkinElmer Revenue Breakdown: Revenue ($m) for Fiscal Year Ending 3rd January 2016
  • Figure 5.3: BD Revenue Breakdown: Revenue ($m), 2015
  • Figure 6.1: Charles River Laboratories Revenue Breakdown: Revenue ($m), 2013-2015
  • Figure 8.1: Strengths and Weaknesses of the Cell-Based Assay Market, 2016
  • Figure 8.2: Strengths and Weaknesses of the Cell-Based Assay Market, 2016
  • Figure 9.1: Projected growth from 2000-2025 with and without a solution for industrialisation of advanced 3D cell-based assays.
  • Figure 9.2: Proportion of Types of Cell Based Assay Used n 2014 and Predicted in 2024
  • Figure 10.1: The Cell-Based Assay Submarket Revenue ($m) Breakdown by Products and Services, 2015, 2020 and 2026
  • Figure 10.2: The Cell-Based Assay Submarket Revenue ($m) Breakdown by Application: Drug Discovery, ADME and Basic Research, 2015, 2020 and 2026
  • Figure 10.3: Regional Breakdown of the Cell-Based Assay Market by Revenue ($m), 2015, 2020 and 2026

Companies Listed

  • Affymetrix
  • Alliance Regenerative Medicine
  • AstraZeneca
  • ATCC
  • Axiogenesis
  • Bayer
  • BBC (British Broadcasting Corporation)
  • BD (Becton, Dickinson and Company)
  • Bio-Rad
  • BioAgilytix
  • BioCity
  • Biocroi
  • Biofocus
  • BioSeek
  • BioVision
  • BMG Labtech
  • CareFusion Corporation
  • Cell Assay Innovations (CAI)
  • Cellartis (Takara Bio)
  • Cellomics
  • Cellular Dynamics
  • Charles River Laboratories
  • Corning
  • Covance
  • CXR Biosciences
  • Cyprotex
  • Cytek
  • CYTOO
  • Di Carlo Laboratory
  • DiscoveRx
  • Dr. Reddy's Laboratories
  • ESI BIO (BioTime)
  • European Lead Factory
  • Eurostars
  • Evotec
  • Fisher Scientific
  • Fluofarma
  • ForteBio
  • Foundation Top Institute Pharma
  • GE Healthcare
  • GenCell
  • General Electric (GE)
  • Harlan Laboratories
  • Hubrecht Institute
  • Imagen Biotech
  • InSphero
  • Janssen
  • Japan Institute of Biomedical Research
  • Jubilant Biosys
  • Lead Discovery Centre GmbH
  • Life Technologies Corporation
  • Marin Biologic Laboratories
  • Maxcyte
  • Merck & Co.
  • Molecular Devices
  • Netherlands Cancer Institute
  • OcellO
  • Organovo
  • PerkinElmer
  • Pharmaceutical Product Development (PPD)
  • Pharmacyclics
  • PharmaTimes
  • Princeton University
  • Promega
  • ProQinase
  • QGel
  • Quintiles
  • ReNeuron
  • ReproCELL
  • Roche
  • Sanofi
  • Seahorse Bioscience
  • SGS (Société Générale de Surveillance)
  • Solvo
  • SRU Biosystems
  • Swiss Federal Institute of Technology
  • SymCel
  • Syncom
  • The European Lead Factory (ELF)
  • The Innovative Medicines Initiative (IMI)
  • The National Health Service (NHS)
  • The Netherlands Cancer Institute
  • The Scientist Magazine
  • Thermo Electron
  • Thermo Fisher Scientific
  • Trinity College, Dublin
  • Tufts Center for the Study of Drug Development
  • UCB (Union Chimique Belge)
  • UCLA (University of California, Los Angeles)
  • UK Department of Health
  • University of Kyoto
  • University of Oxford
  • University of Zurich
  • US Congress
  • US FDA
  • Vala Sciences
  • WuXi
目次
Product Code: PHA0331

The revenue of the cell-based assays market in 2017 is estimated at $13bn and is expected to grow at a CAGR of 9.2% in the first half of the forecast period. Visiongain estimated that the consumables and services segments accounted for 74.26% of the market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 241-page report you will receive 85 tables and 103 figures - all unavailable elsewhere.

The 241-page report provides clear detailed insight into the cell-based assays market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

  • Cell-based Assays market forecasts from 2018-2028
  • Cell-Based Assays Market by Product Type :
  • Instrument
  • Consumables
  • Software
  • Services
  • Reagents
  • Assay Kits
  • Microplates
  • Cell Lines
  • Probes & Labels
  • Cell-Based Assays Market by Application:
  • Drug Discovery
  • Basic Research
  • Predictive Technology
  • Cell-based Assays Market by End-User:
  • Pharma & Biotech Companies
  • Academic Institutes
  • CROs
  • This report provides individual revenue forecasts to 2028 for these national markets:
  • US
  • Japan
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • China
  • India
  • Russia
  • Brazil
  • Our study includes SWOT and STEP analysis of the cell-based assays market.
  • Our study discusses the selected leading companies that are the major players in the cell-based assays market:
  • BD (Becton, Dickinson and Company)
  • BioAgilytix Labs
  • BioVision
  • Cell Assay Innovations, Inc.
  • Charles River Laboratories International
  • CYTOO SA
  • DiscoverX
  • GE Healthcare
  • InSphero
  • Marin Biological Laboratories
  • Molecular Devices
  • Perkin Elmer
  • Pharmaceutical Product Development
  • Porsolt
  • Promega
  • ProQinase GmbH
  • QGel
  • SGS Group, Inc.
  • Thermo Fisher Scientific (and Affymetrix acquisition)

image1

  • This report also discusses technology, trends and future outlook of the cell-based assays industry

Visiongain's study is intended for anyone requiring commercial analyses for the cell-based assays market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Cell-Based Assays Overview
  • 1.2 Cell-Based Assays Market Segmentation
  • 1.3 Why You Should Read This Report
  • 1.4 How This Report Delivers
  • 1.5 Questions Answered by this Report
  • 1.6 Who is this Report for?
  • 1.7 Research Methods and Analysis
  • 1.8 Frequently Asked Questions
  • 1.9 Associated Reports
  • 1.10 About Visiongain

2. Introduction to Cell-Based Assays and Applications

  • 2.1 Cost of New Drug Discovery and Development Reaches $2.6bn - Companies Constantly Looking for Increased Efficiencies
  • 2.2 Drug Discovery Approaches - Target-Based and Phenotype-Based Discovery
  • 2.3 Drug Screening Assays
  • 2.4 Animal Models Present In Vivo Conditions: But Do Results Translate to Humans?
  • 2.5 Biochemical Assays and their Advantages over Animal Models
    • 2.5.1 Applications of Biochemical Assays
    • 2.5.2 Lead Identification and Toxicity Testing
  • 2.6 Cell-Based Assays and their Advantages
  • 2.7 2D vs 3D Cell-Based Assays
  • 2.8 Advanced Cell-Based Assays
  • 2.9 The Different Assay Detection Methods and Technologies
  • 2.10 Cells used in Cell-Based Assays
    • 2.10.1 Immortalised Cell Lines - Convenient but not Truly Representative of Normal Human Cell Lines
    • 2.10.2 Primary Cells: Closer to the In Vivo Environment
    • 2.10.3 Stem Cells: Potential to Overcome Limitations of Primary cells and Immortalised Cell Lines
  • 2.11 Uses for Cell-Based Assays in Drug Discovery and Development
    • 2.11.1 Target Validation
    • 2.11.2 Primary Screening
    • 2.11.3 Secondary Screening
    • 2.11.4 ADME Screening
    • 2.11.5 High Throughput Screening: Greatly Increases Efficiency

3. World Cell-Based Assays Market 2018-2028

  • 3.1 Global Cell-Based Assays Market Forecast 2018-2028
  • 3.2 Drivers for the Cell-Based Assays Market
    • 3.2.1 Growing incidence of chronic diseases
    • 3.2.2 Increasing R&D investment in drug discovery research
    • 3.2.3 Growing adoption of high-throughput screening methodologies
    • 3.2.4 Rapid technological advancements
  • 3.3 Restraints for the Cell-Based Assays Market
    • 3.3.1 High cost of instruments
    • 3.3.2 Dearth of skilled professionals
  • 3.4 Opportunities
    • 3.4.1 Emerging countries to offer lucrative growth opportunities
    • 3.4.2 Growing adoption of label-free cell-based assays
  • 3.5 Trends
    • 3.5.1 3D cell cultures
    • 3.5.2 Microplate readers for cell-based assays
  • 3.6 Cell-Based Assays Market by Products Type: Forecasts 2018-2028
    • 3.6.1 Instrument Segment Forecasts 2018-2028
      • 3.6.1.1 Equipment Needed to Conduct Cell-Based Assays
    • 3.6.2 Consumables Forecasts 2018-2028
      • 3.6.2.1 Reagents Forecasts 2018-2028
      • 3.6.2.2 Assay kits Forecasts 2018-2028
      • 3.6.2.3 Microplates Forecasts 2018-2028
      • 3.6.2.4 Cell lines Forecasts 2018-2028
      • 3.6.2.5 Probes and labels Forecasts 2018-2028
    • 3.6.3 Software Forecasts 2018-2028
    • 3.6.4 Services Forecasts 2018-2028
  • 3.7 Cell-Based Assays Market by Application: Forecasts 2018-2028
    • 3.7.1 Drug Discovery Forecasts 2018-2028
    • 3.7.2 Basic Research Forecasts 2018-2028
    • 3.7.3 Predictive Technology Forecasts 2018-2028
  • 3.8 Cell-based Assays Market by End-User: Forecasts 2018-2028
    • 3.8.1 Pharma & Biotech Companies Forecasts 2018-2028
    • 3.8.2 Academic Institutions Forecasts 2018-2028
    • 3.8.3 Contract Research Organizations (CROs) Forecasts 2018-2028

4. Leading National Markets for Cell-Based Assays, 2018-2028

  • 4.1 Regional Breakdown of the Global Cell-Based Assays Market, 2018-2028
  • 4.2 Global Cell-Based Assays market: Regional Forecast 2017-2028
  • 4.3 The US Cell-Based Assays Revenue Forecast 2018-2028
  • 4.4 European Union (EU) Cell-Based Assays Market 2018-2028
    • 4.4.1 IMI's Pan-European Drug Discovery Platform holds Much Promise
    • 4.4.2 EU National Market Share Breakdown, 2017, 2023 and 2028
    • 4.4.3 EU Market: Main National Forecasts, 2018-2028
    • 4.4.4 German Cell-Based Assay Revenue Forecast, 2018-2028
    • 4.4.5 French Cell-Based Assays Revenue Forecast, 2018-2028
    • 4.4.6 UK Cell-Based Assays Revenue Forecast, 2018-2028
    • 4.4.7 Spanish Cell-Based Assays Revenue Forecast, 2018-2028
    • 4.4.8 Italian Cell-Based Assays Revenue Forecast, 2018-2028
  • 4.5 Japanese Cell-Based Assays Revenue Forecast, 2018-2028
  • 4.6 BRIC Nations (Brazil, Russia, India and China) Cell-Based Assays Market
    • 4.6.1 BRIC Countries National Breakdown, 2017, 2023 and 2028
    • 4.6.2 BRIC Countries National Forecasts, 2018-2028
    • 4.6.3 Chinese Cell-Based assay Revenue Forecast, 2018-2028
    • 4.6.4 Indian Cell-Based Assays Revenue Forecast, 2018-2028
    • 4.6.5 Russian Cell-Based Assays Revenue Forecast, 2018-2028
    • 4.6.6 Brazilian Cell-Based Assays Revenue Forecast, 2018-2028

5. Leading Companies in the Cell-Based Assays Market, 2017

  • 5.1 DiscoverX Corporation (Eurofins)
    • 5.1.1 Business Overview
    • 5.1.2 Company Snapshot
    • 5.1.3 DiscoverX: Cell-based Assay Product Portfolio
    • 5.1.4 DiscoverX: Financial Overview
    • 5.1.5 DiscoverX: Recent Developments
  • 5.2 Thermo Fisher Scientific
    • 5.2.1 Business Overview
    • 5.2.2 Company Snapshot
    • 5.2.3 Thermo Fisher Scientific: Cell-based Assay Product Portfolio
    • 5.2.4 Thermo Fisher Scientific: Financial Overview
    • 5.2.5 Thermo Fisher Scientific: Recent Developments
  • 5.3 Cell Assay Innovations, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Company Snapshot
    • 5.3.3 Cell Assay Innovations: Cell-based Assay Product Portfolio
    • 5.3.4 Cell Assay Innovations: Recent Developments
  • 5.4 InSphero AG
    • 5.4.1 Business Overview
    • 5.4.2 Company Snapshot
    • 5.4.3 InSphero AG: Cell-based Assay Product Portfolio
    • 5.4.4 InSphero AG: Recent Developments
  • 5.5 QGel SA.
    • 5.5.1 Business Overview
    • 5.5.2 Company Snapshot
    • 5.5.3 QGel SA.: Cell-based Assay Product Portfolio
    • 5.5.4 QGel SA.: Recent Developments
  • 5.6 Becton, Dickinson and Company
    • 5.6.1 Business Overview
    • 5.6.2 Company Snapshot
    • 5.6.3 BD.: Cell-based Assay Product Portfolio
    • 5.6.4 BD: Financial Overview
    • 5.6.5 BD: Recent Developments
  • 5.7 Promega Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Company Snapshot
    • 5.7.3 Promega: Cell-based Assay Product Portfolio
    • 5.7.4 Promega Corporation: Recent Developments
  • 5.8 BioVision, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Company Snapshot
    • 5.8.3 BioVision, Inc.: Cell-based Assay Product Portfolio
    • 5.8.4 BioVision, Inc.: Recent Developments
  • 5.9 Marin Biologic Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Company Snapshot
    • 5.9.3 Marin Biologic: Cell-based Assay Product Portfolio
  • 5.10 Molecular Devices, LLC. (Danaher Corporation)
    • 5.10.1 Business Overview
    • 5.10.2 Company Snapshot
    • 5.10.3 Molecular Devices, LLC: Cell-based Assay Product Portfolio
    • 5.10.4 Danaher Corporation: Financial Overview
    • 5.10.5 Molecular Devices, LLC.: Recent Developments
  • 5.11 Porsolt
    • 5.11.1 Business Overview
    • 5.11.2 Company Snapshot
    • 5.11.3 Porsolt: Cell-based Assay Product Portfolio
    • 5.11.4 Porsolt: Recent Developments
  • 5.12 CYTOO SA
    • 5.12.1 Business Overview
    • 5.12.2 Company Snapshot
    • 5.12.3 CYTOO SA: Cell-based Assay Product Portfolio
    • 5.12.4 CYTOO SA: Recent Developments
  • 5.13 Pharmaceutical Product Development, LLC.
    • 5.13.1 Business Overview
    • 5.13.2 Company Snapshot
    • 5.13.3 Pharmaceutical Product Development, LLC: Cell-based Assay Product Portfolio
    • 5.13.4 Pharmaceutical Product Development, LLC.: Recent Developments
  • 5.14 ProQinase GmbH
    • 5.14.1 Business Overview
    • 5.14.2 Company Snapshot
    • 5.14.3 ProQinase GmbH: Cell-based Assay Product Portfolio
  • 5.15 Charles River Laboratories International, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Company Snapshot
    • 5.15.3 Charles River Laboratories International, Inc.: Cell-based Assay Product Portfolio
    • 5.15.4 Charles River Laboratories International, Inc.: Financial Overview
    • 5.15.5 Charles River Laboratories: Recent Developments
  • 5.16 BioAgilytix Labs
    • 5.16.1 Business Overview
    • 5.16.2 Company Snapshot
    • 5.16.3 BioAgilytix Labs: Cell-based Assay Product Portfolio
    • 5.16.4 BioAgilytix Labs: Recent Developments
  • 5.17 SGS Group
    • 5.17.1 Business Overview
    • 5.17.2 Company Snapshot
    • 5.17.3 SGS Group: Cell-based Assay Product Portfolio
    • 5.17.4 SGS Group, Inc.: Financial Overview
    • 5.17.5 SGS Group: Recent Developments
  • 5.18 Perkin Elmer Inc.
    • 5.18.1 Business Overview
    • 5.18.2 Company Snapshot
    • 5.18.3 Perkin Elmer: Cell-based Assay Product Portfolio
    • 5.18.4 Perkin Elmer: Financial Overview
    • 5.18.5 Perkin Elmer: Recent Developments
  • 5.19 General Electric Company (GE Healthcare)
    • 5.19.1 Business Overview
    • 5.19.2 Company Snapshot
    • 5.19.3 General Electric Company.: Cell-based Assay Product Portfolio
    • 5.19.4 General Electric Company: Financial Overview
    • 5.19.5 General Electric Company: Recent Developments

6. Cell-Based Assays Technology, Trends and Future Outlook

  • 6.1 Stem Cells: Vast Potential
    • 6.1.1 The Benefits of Using Stem Cells in Cell-Based Assays
    • 6.1.2 iPSCs: An Uncontroversial and Abundant Source
    • 6.1.3 Companies Providing Stem Cell-Based Assays
  • 6.2 Toxicity Testing: Important Field for Cell-Based Assays
  • 6.3 3D Systems: The Advantages of Next Generation of Cell Systems
    • 6.3.1 Complexity of 3D Systems is a Challenge but More are Reaching the Market
    • 6.3.2 Organoids - The Future of Drug Development
    • 6.3.2.1 Hurdles to the Future Organoid Market
    • 6.3.2.2 Organoids Now and in the Future
    • 6.3.3 Bio-Printing for Drug Development: Using 3D Printing Technology
  • 6.4 Increasing Outsourcing of Cell-Based Assays
  • 6.5 Label-Free Technology
  • 6.6 GPCRs: A Common Drug and Drug Discovery Target
    • 6.6.1 GPCRs in Cell-Based Assays
    • 6.6.2 Allosteric GPCRs
  • 6.7 Increasing Miniaturisation and Automation
    • 6.7.1 Advantages of Miniaturisation
    • 6.7.2 Advantages of Automation
  • 6.8 Microfluids are Set to be a Trend
    • 6.8.1 The Potential Challenges to Microfluids
  • 6.9 Multiplexing: Improves Efficiency of cell-Based Assays
    • 6.9.1 Advantages will Drive Growth
  • 6.10 High Content Screening: A Well-Established Tool
    • 6.10.1 The Future for HCS: Will Continue to Expand, Still Room for Innovation
  • 6.11 Cell-Based Assays for the Development of Biologics

7. Qualitative Analysis of the Cell-Based Assays Market, 2017

  • 7.1 SWOT Analysis of the Cell-Based Assays Market
    • 7.1.1 Strengths Within the Cell-Based Assay Market
    • 7.1.2 Weaknesses Within the Cell-Based Assays Market
    • 7.1.3 Opportunities for the Cell-Based Assays Market
    • 7.1.4 Threats to the Cell-Based Assays Market
  • 7.2 STEP Analysis of the Cell-Based Assays Market
    • 7.2.1 Social Factors
    • 7.2.2 Technological Factors
    • 7.2.3 Economic Factors
    • 7.2.4 Political Factors

8. Conclusions from the Research and Analysis

  • 8.1 Growth Has Been Driven by Advantages of Cell-Based Assays
  • 8.2 Current Status of the Market and its Growth Drivers
  • 8.3 The Most Dominant National Markets and Emerging Countries
  • 8.4 Future Trends and Technology

Appendices

  • Associated Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Report Evaluation Form

List of Figures

  • Figure 1.1 Cell-Based Assays Market Segmented by Application
  • Figure 1.2 Cell-Based Assays Market Segmented by Product
  • Figure 1.2 Cell-Based Assays Market Segmented by End-User
  • Figure 2.1 Stages of Pre-Clinical Drug Development
  • Figure 3.1 Global Cell-Based Assays Market Forecast: Revenue ($m), 2017-2028
  • Figure 3.2 Estimated number of new lung cancer cases worldwide, 2012-2025
  • Figure 3.3 Estimated number of new pancreatic cancer cases worldwide, 2012-2025
  • Figure 3.4 R&D investment of phRMA members between 2011 and 2015
  • Figure 3.5 Drivers and Restraints for the Cell-Based Assays Market, 2018
  • Figure 3.6 Cell-Based Assays Market Segments Forecasts: Revenue ($m), 2017-2028
  • Figure 3.7 Cell-Based Assays Market Segments: Instruments Forecast - Revenue ($m), 2017-2028
  • Figure 3.8 Cell-Based Assays Market Segments: Instruments Forecast -AGR (%), 2017-2028
  • Figure 3.9 Cell-Based Assays Market Segments: Consumables Forecast - Revenue ($m), 2017-2028
  • Figure 3.10 Cell-Based Assays Market Segments: Consumables Forecast -AGR (%), 2017-2028
  • Figure 3.11 Cell-Based Assays Market Segments: Reagents Forecast -AGR (%), 2017-2028
  • Figure 3.12 Cell-Based Assays Market Segments: Reagents Forecast -AGR (%), 2017-2028
  • Figure 3.13 Cell-Based Assays Market Segments: Assay Kits Forecast - Revenue ($m), 2017-2028
  • Figure 3.14 Cell-Based Assays Market Segments: Assay Kits Forecast -AGR (%), 2017-2028
  • Figure 3.15 Cell-Based Assays Market Segments: Microplates Forecast - Revenue ($m), 2017-2028
  • Figure 3.16 Cell-Based Assays Market Segments: Microplates Forecast -AGR (%), 2017-2028
  • Figure 3.17 Cell-Based Assays Market Segments: Cell Lines Forecast - Revenue ($m), 2017-2028
  • Figure 3.18 Cell-Based Assays Market Segments: Cell Lines Forecast -AGR (%), 2017-2028
  • Figure 3.19 Cell-Based Assays Market Segments: Probes and Labels Forecast - Revenue ($m), 2017-2028
  • Figure 3.20 Cell-Based Assays Market Segments: Probes and Labels Forecast -AGR (%), 2017-2028
  • Figure 3.21 Cell-Based Assays Market Segments: Software Forecast - Revenue ($m), 2017-2028
  • Figure 3.22 Cell-Based Assays Market Segments: Software Forecast -AGR (%), 2017-2028
  • Figure 3.23 Cell-Based Assays Market Segments: Services Forecast - Revenue ($m), 2017-2028
  • Figure 3.24 Cell-Based Assays Market Segments: Services Forecast -AGR (%), 2017-2028
  • Figure 3.25 Cell-Based Assays Market Application Forecasts: Revenue ($m), 2017-2028
  • Figure 3.26 Drug Discovery Segment Forecast: Revenue ($m), 2017-2028
  • Figure 3.27 Drug Discovery Segment Forecast: AGR (%), 2017-2028
  • Figure 3.28 Basic Research Segment Forecast: Revenue ($m), 2017-2028
  • Figure 3.29 Basic Research Segment Forecast: AGR (%), 2017-2028
  • Figure 3.30 Predictive Technology Segment Forecast: Revenue ($m), 2017-2028
  • Figure 3.31 Predictive Technology Segment Forecast: AGR (%), 2017-2028
  • Figure 3.32 Cell-Based Assays Market End Users Forecasts: Revenue ($m), 2017-2028
  • Figure 3.33 Pharma & Biotech Companies Forecast: Revenue ($m), 2017-2028
  • Figure 3.34 Pharma & Biotech Companies Forecast: AGR (%), 2017-2028
  • Figure 3.35 Academic Institutes Forecast: Revenue ($m), 2017-2028
  • Figure 3.36 Academic Institutes Forecast: AGR (%), 2017-2028
  • Figure 3.37 CROs Forecast: Revenue ($m), 2017-2028
  • Figure 3.38 CROs Forecast: AGR (%), 2017-2028
  • Figure 4.1 Cell-Based Assays Market Breakdown by Region: Market Shares (%), 2017
  • Figure 4.2 Cell-Based Assays Market Breakdown by Region: Market Shares (%), 2023
  • Figure 4.3 Cell-Based Assays Market Breakdown by Region: Market Shares (%), 2028
  • Figure 4.4 Global Cell-Based Assays Market Regional Forecasts: Revenues ($m), 2017-2028
  • Figure 4.5 US Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
  • Figure 4.6 US Cell-Based Assays Market Forecast: AGR (%), 2017-2028
  • Figure 4.7 EU Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
  • Figure 4.8 EU Cell-Based Assays Market Forecast: AGR (%), 2017-2028
  • Figure 4.9 EU Market Breakdown by Nation: EU Market Shares (%), 2017
  • Figure 4.10 EU Market Breakdown by Nation: Market Shares (%), 2023
  • Figure 4.11 EU Market Breakdown by Nation: Market Shares (%), 2028
  • Figure 4.12 EU Market, Top National Forecasts: Revenue ($m), 2017-2028
  • Figure 4.13 German Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
  • Figure 4.14 German Cell-Based Assays Market Forecast: AGR (%), 2017-2028
  • Figure 4.15 French Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
  • Figure 4.16 French Cell-Based Assays Market Forecast: AGR (%), 2017-2028
  • Figure 4.17 UK Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
  • Figure 4.18 UK Cell-Based Assays Market Forecast: AGR (%), 2017-2028
  • Figure 4.19 Spanish Cell-Based Assays Market Forecast: Revenues($m), 2017-2028
  • Figure 4.20 Spanish Cell-Based Assays Market Forecast: AGR (%), 2017-2028
  • Figure 4.21 Italian Cell-Based Assays Market Forecast: Revenues($m), 2017-2028
  • Figure 4.22 Italian Cell-Based Assays Market Forecast: AGR (%), 2017-2028
  • Figure 4.23 Japanese Cell-Based Assays Market Forecast: Revenues($m), 2017-2028
  • Figure 4.24 Japanese Cell-Based Assays Market Forecast: AGR (%), 2017-2028
  • Figure 4.25 BRIC Countries Breakdown by Nation: Market Shares (%), 2017
  • Figure 4.26 BRIC Countries Breakdown by Nation: Market Shares (%), 2023
  • Figure 4.27 BRIC Countries Breakdown by Nation: Market Shares (%), 2028
  • Figure 4.28 BRIC Countries Breakdown by Nation: Revenues ($m), 2017-2028
  • Figure 4.29 Chinese Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
  • Figure 4.30 Chinese Cell-Based Assays Market Forecast: AGR (%), 2017-2028
  • Figure 4.31 Indian Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
  • Figure 4.32 Indian Cell-Based Assays Market Forecast: AGR (%), 2017-2028
  • Figure 4.33 Russian Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
  • Figure 4.34 Russian Cell-Based Assays Market Forecast: AGR (%), 2017-2028
  • Figure 4.35 Brazilian Cell-Based Assays Market Forecast: Revenue ($m), 2017-2028
  • Figure 4.36 Brazilian Cell-Based Assays Market Forecast: AGR (%), 2017-2028
  • Figure 5.1 Thermo Fisher Scientific: Net Revenues, 2015-2017 ($Million)
  • Figure 5.2 Thermo Fisher Scientific: Net Revenue by Segment, 2017
  • Figure 5.3 Thermo Fisher Scientific: Net Revenue by Geography, 2017
  • Figure 5.4 BD: Net Revenues, 2015-2017 ($Million)
  • Figure 5.5 BD: Net Revenue by Segment, 2017
  • Figure 5.6 BD: Net Revenue by Geography, 2017
  • Figure 5.7 Danaher Corporation: Net Revenues, 2015-2017 ($Million)
  • Figure 5.8 Danaher Corporation: Net Revenue by Segment, 2017
  • Figure 5.9. Danaher Corporation: Net Revenue by Geography, 2017
  • Figure 5.10 Charles River Laboratories: Net Revenues, 2015-2017 ($Million)
  • Figure 5.11 Charles River Laboratories: Net Revenue by Segment, 2017
  • Figure 5.12 Charles River Laboratories: Net Revenue by Geography, 2017
  • Figure 5.13 SGS Group: Net Revenues, 2015-2017 ($Million)
  • Figure 5.14 SGS Group: Net Revenue by Segment, 2017
  • Figure 5.15 SGS Group: Net Revenue by Geography, 2017
  • Figure 5.16 Perkin Elmer Inc.: Net Revenues, 2015-2017 ($Million)
  • Figure 5.17 Perkin Elmer: Segment Revenues, 2015-2017 ($Million)
  • Figure 5.18 General Electric Company: Net Revenues, 2015-2017 ($Million)
  • Figure 5.19 General Electric Company: Net Revenue by Segment, 2017
  • Figure 5.20 General Electric Company: Net Revenue by Geography, 2017
  • Figure 7.1 Strengths and Weaknesses of the Cell-Based Assay Market, 2017
  • Figure 7.2 Strengths and Weaknesses of the Cell-Based Assay Market, 2017
  • Figure 8.1 The Cell-Based Assay Submarket Revenue ($m) Breakdown by Products, 2017, 2023 and 2028
  • Figure 8.2 The Cell-Based Assay Submarket Revenue ($m) Breakdown by Application: Drug Discovery, Basic Research, and Predictive Technology 2017, 2023 and 2028
  • Figure 8.3 Regional Breakdown of the Cell-based Assay Market by Revenue ($m), 2017, 2023 and 2028

List of Tables

  • Table 2.1 Main Parameters Required in Drug Discovery and Development
  • Table 2.2 Selected Label-Free Detection Technologies Used for Cell-Based Assays
  • Table 2.3 Cell-Based Assays for HTS in Drug Screening
  • Table 3.1 Global Cell-Based Assays Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 3.2 Global Cell-Based Assays Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 3.3 Cell-Based Assays Market Segments: Instruments Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
  • Table 3.4 Cell-Based Assays Market Segments: Consumables Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
  • Table 3.5 Cell-Based Assays Market Segments: Reagents Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
  • Table 3.6 Cell-Based Assays Market Segments: Assay Kits Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
  • Table 3.7 Cell-Based Assays Market Segments: Microplates Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
  • Table 3.8 Cell-Based Assays Market Segments: Cell Lines Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
  • Table 3.9 Cell-Based Assays Market Segments: Probes and Labels Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
  • Table 3.10 Cell-Based Assays Market Segments: Software Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
  • Table 3.11 Cell-Based Assays Market Segments: Services Forecast- Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
  • Table 3.12 Cell-Based Assays Market Application Forecasts: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
  • Table 3.13 Drug Discovery Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
  • Table 3.14 Basic Research Segment Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
  • Table 3.15 Predictive Technology Segment Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
  • Table 3.16 Cell-Based Assays Market End-Users Forecasts: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
  • Table 3.17 Pharma & Biotech Companies Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
  • Table 3.18 Academic Institutes Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
  • Table 3.19 CROs Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
  • Table 4.1 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2017
  • Table 4.2 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2023
  • Table 4.3 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2028
  • Table 4.4 Global Cell-Based Assays Market Regional Forecasts: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2017-2028
  • Table 4.5 US Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Shares (%), CAGR (%), 2017-2028
  • Table 4.6 EU Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), World Market Shares (%), CAGR (%), 2017-2028
  • Table 4.7 EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2017
  • Table 4.8 EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2023
  • Table 4.9 EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2028
  • Table 4.10 EU Market, Leading Five National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
  • Table 4.11 German Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
  • Table 4.12 French Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
  • Table 4.13 UK Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
  • Table 4.14 Spanish Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
  • Table 4.15 Italian Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
  • Table 4.16 Japanese Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
  • Table 4.17 BRIC Countries Breakdown by Nation: BRIC market Shares (%), Global Market Shares (%) and Revenues ($m), 2017
  • Table 4.18 BRIC Countries Breakdown by Nation: EU market Shares (%), Global Market Shares (%) and Revenues ($m), 2023
  • Table 4.19 BRIC Countries Breakdown by Nation: EU market Shares (%), Global Market Shares (%) and Revenues ($m), 2028
  • Table 4.20 BRIC National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
  • Table 4.21 Chinese National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
  • Table 4.22 Indian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
  • Table 4.23 Russian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
  • Table 4.24 Brazilian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
  • Table 5.1 DiscoverX: Company Profile
  • Table 5.2 DiscoverX: Cell-based Assay Product Portfolio
  • Table 5.3 Thermo Fisher Scientific, Inc.: Company Profile
  • Table 5.4 Thermo Fisher Scientific, Inc.: Cell-based Assay Product Portfolio
  • Table 5.5 Cell Assay Innovations, Inc.: Company Profile
  • Table 5.6 Cell Assay Innovations, Inc.: Cell-based Assay Product Portfolio
  • Table 5.7 InSphero AG: Company Profile
  • Table 5.8 InSphero AG: Cell-based Assay Product Portfolio
  • Table 5.9 QGel SA.: Company Profile
  • Table 5.10 QGel SA.: Cell-based Assay Product Portfolio
  • Table 5.11 Becton, Dickinson and Company: Company Profile
  • Table 5.12 Becton, Dickinson and Company: Cell-based Assay Product Portfolio
  • Table 5.13 Promega Corporation: Company Profile
  • Table 5.14 Promega Corporation: Cell-based Assay Product Portfolio
  • Table 5.15 BioVision, Inc.: Company Profile
  • Table 5.16 BioVision, Inc.: Cell-based Assay Product Portfolio
  • Table 5.17 Marin Biologic Laboratories: Company Profile
  • Table 5.18 Marin Biologic Laboratories: Cell-based Assay Product Portfolio
  • Table 5.19 Molecular Devices, LLC.: Company Profile
  • Table 5.20 Molecular Devices, LLC.: Cell-based Assay Product Portfolio
  • Table 5.21 Porsolt: Company Profile
  • Table 5.22 Porsolt: Cell-based Assay Product Portfolio
  • Table 5.23 CYTOO SA: Company Profile
  • Table 5.24 CYTOO SA: Cell-based Assay Product Portfolio
  • Table 5.25 Pharmaceutical Product Development, LLC.: Company Profile
  • Table 5.26 Pharmaceutical Product Development, LLC.: Cell-based Assay Product Portfolio
  • Table 5.27 ProQinase GmbH: Company Profile
  • Table 5.28 ProQinase GmbH: Cell-based Assay Product Portfolio
  • Table 5.29 Charles River Laboratories International, Inc.: Company Profile
  • Table 5.30 Charles River Laboratories International, Inc.: Cell-based Assay Product Portfolio
  • Table 5.31 BioAgilytix Labs: Company Profile
  • Table 5.32 BioAgilytix Labs: Cell-based Assay Product Portfolio]
  • Table 5.33 SGS Group: Company Profile
  • Table 5.34 SGS Group: Cell-based Assay Product Portfolio
  • Table 5.35 Perkin Elmer Inc.: Company Profile
  • Table 5.36 Perkin Elmer Inc.: Cell-based Assay Product Portfolio
  • Table 5.37 General Electric: Company Profile
  • Table 6.1 Selected Companies with Involvement in Stem Cell-Based Assays
  • Table 6.2 Selected Companies Offering Label-Free Assay Systems
Back to Top